Intravenous Infusions (XGHA:IIL) Other Financing : GHS0.00 Mil (TTM As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Other Financing?

Intravenous Infusions's Other Financing for the six months ended in . 20 was GHS0.00 Mil.

Intravenous Infusions's Other Financing for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Other Financing Historical Data

The historical data trend for Intravenous Infusions's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Other Financing Chart

Intravenous Infusions Annual Data

Trend

Other Financing

Intravenous Infusions Semi-Annual Data

Other Financing

Intravenous Infusions Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Other Financing Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.